Dr Harsh Vardhan launches CuRED, CSIR partnered clinical trials website

New Delhi [India], October 21 (ANI): Union Health and Science and Technology Minister Dr Harsh Vardhan launched CuRED, a website that gives comprehensive info about the numerous COVID-19 clinical trials that the Council of Scientific & Industrial Research (CSIR) is engaged in partnership with industry, other government departments and ministries.

CSIR Ushered Repurposed Drugs (CuRED) provides information about the drugs, diagnostics and devices including the current stage of the trials, partnering institutions and their role in the trials and other details, as per a release by the Science & Technology Ministry.
Dr Harsh Vardhan lauded CSIR’s efforts in being at the forefront of the fight against COVID-19 and giving priority to clinical trials, generating data for their regulatory approval and helping launch drugs and diagnostics in the market.
CSIR is exploring multiple combination clinical trials of anti-virals with host-directed therapies for the potential treatment of COVID-19. It is also working

Read More

Fastly Delivers a Harsh Lesson on Software’s Valuation Excesses

Software stocks have been among the best performers of 2020, juiced by revenue growth related to stay-at-home measures and lofty expectations for future gains. But a blowup at cloud provider Fastly Inc. served as a stark reminder of how some of those hopes may prove misguided.

Fastly plummeted as much as 31%, its worst session on record, after a revenue warning for the third quarter rebutted a growth narrative that had made the company the fifth-best performer in the Russell 1000 Index this year. While some of the weakness was related to geopolitical tensions and its exposure to TikTok owner ByteDance, Fastly also warned of reduced revenue from other customers.

Fastly’s slowdown highlights the precariousness of lofty software valuations. Massive share plunges are the price paid when these businesses fall short of perfection. Software stocks have been among the year’s leaders, with an S&P index of software makers up more

Read More